|
28 Apr 2007 |
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
|
|
28 Apr 2007 |
FDA approves once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray for treatment of seasonal and year-round allergy symptoms in adults and children as young as two years
|
|
28 Apr 2007 |
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
|
|
27 Apr 2007 |
Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
|
|
27 Apr 2007 |
Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
|
|
27 Apr 2007 |
SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
|
|
27 Apr 2007 |
4SC AG: 60 Patients in Phase IIa Clinical Trial
|
|
27 Apr 2007 |
Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
|
|
26 Apr 2007 |
Exelixis Files IND Application for XL765
|
|
26 Apr 2007 |
XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
|
|
26 Apr 2007 |
MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
|
|
26 Apr 2007 |
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
|
|
26 Apr 2007 |
Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
|
|
26 Apr 2007 |
ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
|
|
26 Apr 2007 |
Vanda Pharmaceuticals Initiates Phase II Clinical Trial for VSF-173 in Excessive Sleepiness
|
|
26 Apr 2007 |
Ceragenix Commences Second in Series of Clinical Trials
|
|
26 Apr 2007 |
SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With MP470
|
|
26 Apr 2007 |
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
|
|
26 Apr 2007 |
Resverlogix Announces Milestone ApoA-l/HDL Proof-of-Concept Data
|
|
25 Apr 2007 |
NeuroSearch and GlaxoSmithKline initiate second clinical Phase II study with NS2359 in depression
|
|
25 Apr 2007 |
TopoTarget announces next Phase II clinical placebo controlled trial with Avugane(TM) in acne vulgaris
|
|
25 Apr 2007 |
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
|
|
25 Apr 2007 |
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
|
|
25 Apr 2007 |
Lexicon Advances LX1031 for Irritable Bowel Syndrome into Phase 1b Clinical Trial
|
|
25 Apr 2007 |
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
|
